CINXE.COM

<!DOCTYPE html> <html xmlns="http://www.w3.org/1999/xhtml" class="no-js" lang="en" xml:lang="en"> <head><script type='text/javascript'>window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('consent', 'default', { ad_storage: 'denied', analytics_storage: 'denied', functionality_storage: 'denied', personalization_storage: 'denied', security_storage: 'granted', ad_user_data: 'denied', ad_personalization: 'denied', 'wait_for_update': 500 }); </script> <script type='text/javascript' src='https://cdn.cookielaw.org/consent/a8db6e5f-20c8-46f0-86d7-2835a0229013/OtAutoBlock.js' ></script> <script src='https://cdn.cookielaw.org/scripttemplates/otSDKStub.js' data-document-language='true' type='text/javascript' charset='UTF-8' data-domain-script='a8db6e5f-20c8-46f0-86d7-2835a0229013'></script> <script type='text/javascript'>function OptanonWrapper() { }</script><meta http-equiv="Content-Type" content="text/html; charset=UTF-8" /> <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-TXRMXF');</script><title>Funding history — Laboratory of Intensive Care Medicine</title><meta charset="utf-8" /><meta name="twitter:card" content="summary" /><meta property="og:site_name" content="Groep Biomedische Wetenschappen KU Leuven" /><meta property="og:title" content="Funding history" /><meta property="og:type" content="website" /><meta property="og:description" content="" /><meta property="og:url" content="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history" /><meta property="og:image" content="https://gbiomed.kuleuven.be/++resource++plone-logo.svg" /><meta property="og:image:type" content="image/svg+xml" /><meta name="DC.date.created" content="2022-09-27T10:16:38+01:00" /><meta name="DC.date.modified" content="2023-03-01T13:03:25+01:00" /><meta name="DC.type" content="Page" /><meta name="DC.format" content="text/html" /><meta name="DC.language" content="en" /><meta name="DC.date.valid_range" content="2023/03/01 - " /><meta name="viewport" content="width=device-width, initial-scale=1.0" /> <link rel="icon" type="image/png" href="//stijl.kuleuven.be/releases/latest/img/favicon.png" /> <link rel="canonical" href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history" /><link href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/@@search" rel="search" title="Search this site" /><link data-bundle="collective.quickupload.uploadify" href="https://gbiomed.kuleuven.be/++webresource++d8447c31-cb62-5e50-b3f2-90af0e386241/++resource++quickupload_static/uploadify.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="collective.quickupload.fileuploader" href="https://gbiomed.kuleuven.be/++webresource++87d24f12-da88-5fca-8657-21c181543c6b/++resource++quickupload_static/fileuploader.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="easyform" href="https://gbiomed.kuleuven.be/++webresource++b6e63fde-4269-5984-a67a-480840700e9a/++resource++easyform.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="faceted.jquery" href="https://gbiomed.kuleuven.be/++webresource++d5804eac-48ee-5c69-8389-75ac65829cb3/++plone++facetednavigation/faceted-jquery.min.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="faceted.view" href="https://gbiomed.kuleuven.be/++webresource++96c3556c-9d70-5d58-951a-ff5109db53b8/++plone++facetednavigation/faceted-view.min.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="faceted.edit" href="https://gbiomed.kuleuven.be/++webresource++688bdb99-253c-5b8b-bd8b-90f9b92d6ab0/++plone++facetednavigation/faceted-edit.min.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="kuleuven-fonts-css" href="https://fonts.googleapis.com/css2?family=Material+Icons&family=Source+Sans+Pro:ital,wght@0,400;0,600;0,700;1,400;1,600;1,700&family=Source+Serif+Pro:ital,wght@0,400;0,600;0,700;1,400;1,600;1,700&display=swap" media="all" rel="stylesheet" type="text/css" /><link data-bundle="kuleuven-staff-bundle" href="https://gbiomed.kuleuven.be/++webresource++8b0aff1f-678f-5b2f-9281-18c72aeca304/++plone++kuleuven.staff/staff.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="kuleuven-theme-bundle" href="https://gbiomed.kuleuven.be/++webresource++f6837a84-ffdc-5446-bc7f-821bcf0724b9/++theme++ku-leuven-theme/styles/theme.min.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="kuleuven-housestyle-css" href="https://stijl.kuleuven.be/releases/ttt/css/wms.css" media="all" rel="stylesheet" type="text/css" /><link data-bundle="plone-fullscreen" href="https://gbiomed.kuleuven.be/++webresource++ac83a459-aa2c-5a45-80a9-9d3e95ae0847/++plone++static/plone-fullscreen/fullscreen.css" media="all" rel="stylesheet" type="text/css" /><script data-bundle="plone-fullscreen" integrity="sha384-yAbXscL0aoE/0AkFhaGNz6d74lDy9Cz7PXfkWNqRnFm0/ewX0uoBBoyPBU5qW7Nr" src="https://gbiomed.kuleuven.be/++webresource++6aa4c841-faf5-51e8-8109-90bd97e7aa07/++plone++static/plone-fullscreen/fullscreen.js"></script><script data-bundle="plone" integrity="sha384-aijz8WVywzoa9lW2citE/nPhYzJWHx2WKnRy2c7wRzQah6h45fib0hUCiqZycFjv" src="https://gbiomed.kuleuven.be/++webresource++ad7863d4-668c-5639-96bb-0c5c4c46d54b/++plone++static/bundle-plone/bundle.min.js"></script><script async="True" data-bundle="faceted.jquery" defer="True" integrity="sha384-Ofmq/ugkJSU/yCLuiyhTTiB+b5JnrNeXCgK7gkjNaIKwYnXpnyv1jSFyMSf3fPjC" src="https://gbiomed.kuleuven.be/++webresource++a4f06bff-41b9-589a-9c53-a3cae5dd93e3/++plone++facetednavigation/faceted-jquery.min.js"></script><script async="True" data-bundle="faceted.view" defer="True" integrity="sha384-+T6rtFxLhdfgxF6bbwq83ndwLqPQicaVp/cgM61jwK3O2tBhnYjhLndj84A5UfTm" src="https://gbiomed.kuleuven.be/++webresource++f1d185e2-8a9a-5a28-b6b7-0b6e4bbf35da/++plone++facetednavigation/faceted-view.min.js"></script><script async="True" data-bundle="faceted.edit" defer="True" integrity="sha384-vEz64MVbeerkh5k5x5CpPxZBe3O7ZML/rmSlWwicW7HjBmTOLtFVct6iPUKfHWDo" src="https://gbiomed.kuleuven.be/++webresource++9ff7b2fc-bb60-5b7e-a094-49a1fe46d833/++plone++facetednavigation/faceted-edit.min.js"></script><script data-bundle="collective.quickupload.uploadify" integrity="sha384-C4/VF8nQO87QjMQdclEh0bMunovnrQvDgyAd8maZRAMo0FVdl6gbTZRcOT2mqZ43" src="https://gbiomed.kuleuven.be/++webresource++9632347a-86f7-5a0b-b950-5e96d3f3f53a/++resource++quickupload_static/jquery.uploadify.js"></script><script data-bundle="collective.quickupload.fileuploader" integrity="sha384-0kcuY/Fi19SNhcChNhPKDcFFbdtazE+ECSubAEZeNspuYXpEkST+UhkahlNlDejC" src="https://gbiomed.kuleuven.be/++webresource++43a69a20-361e-50af-abb1-f4296d386cc5/++resource++quickupload_static/fileuploader.js"></script><script data-bundle="collective.quickupload.helpers" integrity="sha384-199pRmTitY4DH7qig/ad/LPwO/62+w9uDVubX9RSm6y1zH9w803qMUUdYHsQhEaY" src="https://gbiomed.kuleuven.be/++webresource++6b561814-6710-588e-97de-39bd8c949a5b/++resource++quickupload_static/helpers.js"></script><script> require = undefined; define = undefined; </script></head> <body id="visual-portal-wrapper" dir="ltr" class="at_gbiomed - col-content frontend icons-on portaltype-document section-funding-history site-laboratory-of-intensive-care-medicine template-document_view thumbs-on userrole-anonymous viewpermission-view" data-base-url="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history" data-view-url="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history" data-portal-url="https://gbiomed.kuleuven.be" data-i18ncatalogurl="https://gbiomed.kuleuven.be/plonejsi18n" data-pat-pickadate="{"date": {"selectYears": 200}, "time": {"interval": 5 } }" data-pat-plone-modal="{"actionOptions": {"displayInModal": false}}"><section id="edit-bar" role="toolbar"></section><div class="l-page">  <nav class="global-header noindex hidden-print"> <div class="container"> <a class="navbar-brand" href="https://www.kuleuven.be/english/"><img class="logo" alt="logo" src="https://stijl.kuleuven.be/releases/latest/img/svg/logo.svg" width="157" height="56" /></a> <div class="controls"> <a class="btn btn-ext btn-home" href="https://www.kuleuven.be/english/">KU Leuven Home</a> <a href="#" class="btn-toggle js-flyout-toggle flyout-toggle collapsed" role="button" aria-expanded="false" aria-controls="flyout-local-menu" data-toggle="collapse" data-target="#flyout-local-menu"><span class="lines"></span></a> </div> </div> </nav>   <nav class="local-header"> <div class="container container-relative"> <nav class="nav-header"> <h2> <a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine"> Laboratory of Intensive Care Medicine </a> <a href="#" class="btn-toggle hidden-lg-up" role="button" aria-expanded="false" data-toggle="collapse" data-target="#local-header" aria-controls="local-header"><span class="lines"></span></a> </h2> </nav> <nav class="nav-tabs nav-more collapse" id="local-header"> <ul id="portal-globalnav"><li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/research">Research</a></li><li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/group-members">Group members</a></li><li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/phd-projects">Students</a></li><li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/study-protocols">Study Protocols</a></li><li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history">Funding history</a></li><li><a href="https://www.uzleuven.be/nl/intensieve-geneeskunde">Intensive Care Unit Hospital</a></li></ul> </nav> </div> </nav>  <div class="kuleuven-banner"></div>  <div role="main"> <div class="container"> <div class="row"> <aside id="global_statusmessage"> <div> </div> </aside> </div> <div class="row">  <div id="above-content" class="col-xs-12"> <nav id="portal-breadcrumbs" aria-label="breadcrumb"> <div class="container"> <ol class="breadcrumb"> <li class="breadcrumb-item"><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine">Home</a></li> <li class="breadcrumb-item active" aria-current="page">Funding history</li> </ol> </div> </nav> </div> <div class="col-xs-12 col-sm-12">  <div class="row"> <div class="col-xs-12 col-sm-12"> <article id="content"> <header> <div id="viewlet-above-content-title"><span id="social-tags-body" itemscope="" itemtype="http://schema.org/WebPage" style="display: none"> <span itemprop="name">Funding history</span> <span itemprop="description"></span> <span itemprop="url">https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history</span> <span itemprop="image">https://gbiomed.kuleuven.be/++resource++plone-logo.svg</span> </span> </div> <h1>Funding history</h1> <div id="viewlet-below-content-title"></div>   <div id="viewlet-below-content-description"></div> </header> <div id="viewlet-above-content-body"> </div> <div id="content-core"> <section id="section-text"> <div data-pat-autotoc="prependTo:#autotoc-container;levels:h1,h2,h3,h4" class="" id="parent-fieldname-text"><h3><a href="#eurofunf">European</a> - <a href="#natfund">National</a> - <a href="#univfund">Institutional</a> competitive funding and <a href="#fellowships">fellowships</a></h3> <h4><a id="eurofunf" name="eurofunf"></a>European Funding</h4> <ul> <li> <p>ERC advanced grant (AdG-2017-785809) from the European Union’s Horizon 2020 research and innovation program: FitteR-CATABOLIC: Survival of the fittest: On how to enhance recovery from critical illness through learning from evolutionary conserved catabolic pathways (2018-2023)</p> </li> <li> <p>ERC advanced grant (AdvG – 2012 – 321670) van het “Ideas Program” van de EU FP7 Nutri-CARE: Nutrient restriction during Critical illness: from induction of autophagy to repression of aberrant epigenetic alterations (2013-2018)</p> </li> <li> <p>EU KP6-IST - EU Information Society Technologies : “CLINICIP: Closed Loop Insulin Infusion for Critically Ill Patients” contract nr. 506965 (CLINICIP) (2004-2008)</p> </li> </ul> <h4><a id="natfund" name="natfund"></a>National Funding</h4> <ul> <li> <p><a href="https://www.kuleuven.be/onderzoek/portaal/#/projecten/3M210031">FWO - Impact of duration of critical illness on cholesterol availability in relation to outcome. FWO project (2021-2024). Promotors: Lies Langouche & Greet Van den Berghe</a></p> </li> <li> <p><a href="https://www.kuleuven.be/onderzoek/portaal/#/projecten/3M220233?hl=en&lang=en">FWO-Medium Scale Infrastructure - A novel hybrid metabolomics platform combining the power of gas chromatography seperation with high resolution, high-accuracy mass spectrometry of full precursor massess. (2022-2026) Promotors: Bart Ghesquière, Lies Langouche, Peter Witters, Ina Jochmans</a></p> </li> <li> <p><a href="https://www.kuleuven.be/onderzoek/portaal/#/projecten/3M200014?hl=en&lang=en">FWO - Impact of acute and possibly permanent neuro-endocrine changes on critical illness induced muscle weakness and its legacy. FWO project (2020-2023) Promotor: Greet Hermans</a></p> </li> <li> <p>FWO - Intensive care extended beyond the “adaptive” time window: from impact on the adrenocortical ‘fight or flight’ response towards a possible new treatment. FWO project (2018-2021) Promotor: Greet Van den Berghe</p> </li> <li> <p>FWO-TBM - The effectiveness of algorithm-guided blood glucose control within normal fasting ranges with insulin in adult critically ill patients (‘TGC-fast’) Promotors: Greet Van den Berghe, Jan Gunst</p> </li> <li> <p>FWO - Protective potential of obesity against critical illness induced muscle wasting. FWO project G. (2017-2021) Promotors: Lies Langouche, Greet Van den Berghe </p> </li> <li> <p>FWO - The role of glucagon and endocrine FGFs in orchestrating the complex endocrine and metabolic responses to critical illness. FWO project G.0848.15N (2015-2020) Promotors: Ilse Vanhorebeek, Greet Van den Berghe</p> </li> <li> <p>IWT-TBM - Medical risks and developmental deficit 4 years after pediatric critical illness: role of exposure to plastic softeners released from indwelling medical devices (MeDIPlasticS). IWT YBM 150181 (2015-2019)</p> </li> <li> <p>IWT - TBM - The Paediatric Early versus Late Parenteral Nutrition in Critical Illness (PEPaNIC) multicentre randomised controlled study. IWT TBM 110685 (2012-2016)</p> </li> <li> <p>IWT - TBM - The single-centre and multi-centre clinical validation of an algorithm to control blood glucose levels in critically ill patients. IWT TBM 100793 (2011-2015)</p> </li> <li> <p>IWT - SBO - Early warning monitoring system for prediction of disease outcome and for design of life saving therapy in sepsis and inflammation “EPOS” IWT SBO 80040 (2009-2012)</p> </li> <li> <p>IWT - TBM - Tight glycaemic control with intensive insulin therapy in critically ill children: impact on acute and long-term outcome. IWT TBM 070695 (2008 - 2011)</p> </li> <li> <p>FWO - Impaired autophagy as a key player in critical illness-induced muscle weakness. FWO project G.0592 (2012-2015)</p> </li> <li> <p>FWO - Persisting muscle weakness after prolonged intensive care stay: incidence, risk factors, pathophysiology and contribution to long-term physical disabilities. FWO project G.0399.12 (2012-2015)</p> </li> <li> <p>FWO - Cause and consequence of the altered cortisol metabolism and the role of bile acids during critical illness. FWO project G041712N (2012-2015)</p> </li> <li> <p>FWO - Metabolic stress, mitochondrial dynamics and organ failure during critical illness: towards a novel therapeutic intervention. FWO project G.0860.11 (2011-2014).</p> </li> <li> <p>FWO - Clinical prediction models in intensive care FWO project G.0904.11 (2011-2014)</p> </li> <li> <p>FWO - Metabolic aspects of organ failure in critical illness: role of blood glucose levels and variation of nutritional intake. FWO project G.0585.09 (2009-2012)</p> </li> <li> <p>FWO - Regulation of the thyroid axis during critical illness: a study of the peripheral changes during the low T3 syndrome - exploring safe reactivation strategies. FWO project G.0578.09 (2009-2012)</p> </li> <li> <p>FWO - Optimization and implementation of a control system aiming the normalization of glycemia in critically ill patients. FWO project G.0557.08 (2008 - 2011)</p> </li> <li> <p>FWO - Learning in large relational databases with an application in intensive care medicine. FWO project G.0310.08 (2008 - 2011)</p> </li> <li> <p>FWO - Signal transduction pathways and cellular and molecular mechanisms behind improved survival of critial illness. FWO project G.0533.06 (2006 - 2009)</p> </li> <li> <p>FWO - Regulation of the thyroid axis during critical illness: an exploration of the central and peripheral alterations in the low T3 syndrome. FWO project G.0258.05 (2005 - 2008)</p> </li> <li> <p>FWO - Study of the mechanisms which underly the life-saving effects of strict glycemic control with insulin in critically ill patients. FWO project G.0278.03 (2003-2006)</p> </li> <li> <p>FWO - Control for intensive care glycemia. FWO project G.0491.03 (2003-2006)</p> </li> <li> <p>FWO - Neuro-endocrinology of protracted critical illness. FWO project G.0144.00 (2000-2003)</p> </li> <li> <p>FWO - The thyroid axis in critical illness. FWO project G.0162.96 (1996-1999)</p> </li> <li> <p>Research Grant from the Belgian Study Group for Pediatric Endocrinology (1994, 1995, 1996)</p> </li> </ul> <h4><a id="univfund" name="univfund"></a>Funding through the University</h4> <ul> <li><a href="https://www.kuleuven.be/onderzoek/onderzoeksdatabank/project/3E15/3E150389.htm">METHUSALEM - Research Fund of the KULeuven: Interfering with metabolism during critical illness: from acute outcome to longterm consequences (INherit) (2017-2024)</a><a href="https://www.kuleuven.be/onderzoek/portaal/#/projecten/3E150389"> Promotors Greet Van den Berghe, Lies Langouche, Ilse Vanhorebeek</a> <p><a href="https://www.kuleuven.be/onderzoek/portaal/#/projecten/3M210821?hl=en&lang=en">C3-project: TB-AI: advanced analytics for the management of traumatic brain injury (2022-2025). Promotor: Geert Meyfroidt</a></p> </li> <li> <p>C2-project: Activating Autophagy by Alternative Feeding Strategies and Functional Outcome of ICU and Major Surgery Patients: ACT-FEED (2017-2021) Promotors Michael Casaer, Willy Coosemans and Jan Gunst</p> </li> <li> <p>C2-project: A neuromonitor for the 21st century (2017-2021) Promotors Geert Meyfroidt and Fabian Guïza</p> </li> <li> <p>BOF startfinanciering: ICU-FM: design and validation of a fasting mimicking diet for the critically ill: Extending the borders of autophagy-activation and monitoring and broadening the beneficial application of nutrition restriction in acute illness (01/10/2016-30/09/2018). (Micael Casaer)</p> </li> <li> </li> <li> <p>METHUSALEM - Research Fund of the KULeuven: Endocrine and metabolic aspects of organ failure in critical illness: perspectives for prevention and therapy. (2008 – 2016)</p> </li> <li> <p>IOF-hefboomproject: Defective autophagy and multiple organ failure during critical illnesrds a novel life-saving therapy (01/10/2010 - 30/09/2011)</p> </li> <li> <p>IOF-hefboomproject: Clinical validation and filing for regulatory approval of a blood glucosator for the Intensive Care Unit. (01/08/2010 - 30/07/2011)</p> </li> <li> <p>GOA - Research Fund of the K.U.Leuven: On the altered endocrine and metabolic status of the critically ill: impact on organ function and survival – mechanisms of action. Grant nr. GOA 2007/14 (/2006 - 2011)</p> </li> <li> <p>IDO - Research Fund of the K.U.Leuven: Developing significant predictive models in critical illness. Grant nr. IDO 03/006 (2004 - 2007)</p> </li> <li> <p>OT - Research Fund of the K.U.Leuven: Life-saving effects of intensive insulin therapy in the critically ill: mechanisms of action. Grant nr. OT/03/56 (2003-2007)</p> </li> <li> <p>OT - Research Fund of the K.U.Leuven: Grant nr. OT/99/32 (1999-2003)</p> </li> <li> <p>OT - Research Fund of the K.U.Leuven: Grant nr. OT/95/24 (1995-1999)</p> </li> </ul> <h4><a id="fellowships" name="fellowships"></a> Fellowships</h4> <h5>Doctoral fellowships</h5> <ul> <li> <p>Carra Giorgia - FWO fellowship (aspirant PhD): Artificial intelligence for individualized decision support in traumatic and non-traumatic brain injured patients (01/11/2019-31/10/2023) </p> </li> <li> <p>Téblick Arno - Doctoraal beleidsmandaat - The HPA axis alterations in critical illness (01/10/2018- 30/09/2019) </p> </li> <li> <p>Van Aerde Nathalie - FWO fellowship (aspirant PhD): The long-term legacy of prolonged critical illness in the muscle: mechanisms and clinical impact (01/10/2017-30/09/2021)</p> </li> <li> <p>Lisa Van Dyck - FWO fellowship (aspirant PhD): Nutritional interventions in the intensive care unit: impact on muscle weakness in relation to the epigenetic signature in muscle (01/10/2017-30/09/2021)</p> </li> <li> <p>Marine Flechet - FWO fellowship (aspirant PhD):Optimizing brain perfusion in critical illness and acute brain injury: bringing computer models to the bedside (01/10/2015-30/09/2019)</p> </li> <li> <p>Bram Peeters - FWO fellowship (aspirant PhD): HPA axis in critical illness: cause and consequence of altered cortisol metabolism (01/10/2014-30/09/2018)</p> </li> <li> <p>Sören Verstraete - FWO fellowship (aspirant PhD): On epigenetics and how 'environmental' factors contribute to the long-term legacy of pediatric critical illness (01/10/2014-30/09/2018)</p> </li> <li> <p>Steven Thiessen – FWO fellowship (aspirant PhD): Recovery from critical illness: role of autophagy and epigenetics (01/10/2013-30/09/2017)</p> </li> <li> <p>Catherine Ingels – FWO fellowship (clinical PhD): Insulin, nutrition and the innate immune response to critical illness (01/10/2013 – 30/09/2015)</p> </li> <li> <p>Catherine Ingels - KOF fellowship: Modulation of late innate immune responses in critical illness: impact of insulin and vitamin D (01/04/2009-31/03/2012)</p> </li> <li> <p>Sandra Verelst - FWO clincial fellowship: Emergency department crowding and the relation to adverse event occurrence and its characteristics. Promotion date 06/02/2014</p> </li> <li> <p>Michael Casaer - FWO clincial fellowship: Impact of early parenteral nutrition on metabolism, morbidity and mortality in critically ill patients. Promotion date 21/12/2012</p> </li> <li> <p>Jan Gunst - FWO fellowship: Prevention of glucose toxicity prevents renal damage during critical illness: mechanistic studies in a rabbit model. Promotion date 2/10/2012</p> </li> <li> <p>Marijke Gielen - FWO fellowship: Strict glycemic control with intensive insulin therapy in critically ill children: impact on outcome, inflammatory response and the neuroendocrine axes. Promotion date 25/09/2012</p> </li> <li> <p>Geert Meyfroidt - KOF and clinical FWO fellowship (3M050541): Developing significant predictive models in critical illness. Promotion date 02/03/2010</p> </li> <li> <p>Dirk Vlasselaers - KOF and clinical FWO fellowship (3M050600): Tight glycemic control with intensive insulin therapy: Effects on inflammation, endothelial and myocardial function and the facilitation of clinical implementation. Promotion date 22/10/2008</p> </li> <li> <p>Yves Debaveye - FWO fellowship: The low T3 syndrome during prolonged critical illness. Promotion date 17/09/2007</p> </li> <li> <p>Dieter Mesotten - FWO fellowship and Collen Research fund : Mechanisms of growth hormone- and insulin- induced alterations in metabolism during critical illness. Promotion date 26/11/2003</p> </li> </ul> <h5>Postdoctoral fellowships</h5> <ul> <li> <p>Chloë Goossens - BOF-PDM kort postdoc fellowship: Optimization of ketone body supplementation to protect against ICU-acquired weakness (01/01/2018-31/12/2018)</p> </li> <li> <p>Greet Hermans - FWO Clinical Researcher: Nutritional interventions in the ICU: impact on muscle weakness in relation to the epigenetic signature in muscle</p> </li> <li> <p>Catherine Ingels - KOF mandaat klinisch onderzoeker: impact of macronutrient restriction during the early phase of critical illness on the innate immune response (2016-2019)</p> </li> <li> <p>Michaël Casaer - FWO Clinical Researcher: ICU-FM: design and validation of a fasting mimicking diet for the critically ill (2016-2021) </p> </li> <li> <p>Geert Meyfroidt – FWO clinical researcher: Development and clinical validation of novel tools to monitor critical alterations in intracranial pressure, cerebrovascular autoregulation, and cerebral oximetry in brain injured patients and critically ill children. (2012-2017)</p> </li> <li> <p>Dieter Mesotten - FWO clinical researcher: Liver dysfunction and its hormonal regulation during acute and protracted critical illness. (01/10/2012-30/09/2017)</p> </li> <li> <p>Liese Mebis - BOF- PDM kort-postdoc fellowship: The pathogenesis of the non-thyroidal illness syndrome: from premature birth to adult critical illness. (01/10/10-30/09/11)</p> </li> <li> <p>Helen Owen - BOF- F+postdoc fellowship: Bone metabolism and repair during critical illness. (01/03/2010-28/02/2011)</p> </li> <li> <p>Sophie Van Cromphaut - FWO clinical research investigator: Calcium and bone homeostasis in acute and prolonged critical illness. (01/10/2008-30/09/2013)</p> </li> <li> <p>Dieter Mesotten - KOF clinical researcher: Liver dysfunction and its hormonal regulation during acute and protracted critical illness. (01/10/2008-30/09/2010)</p> </li> <li> <p>Lies Langouche - FWO postdoc fellowship: Impact of metabolic interventions on the endocrine system of the critically ill. (01/10/2008-30/09/2011)</p> </li> <li> <p>Ilse Vanhorebeek - BOF postdoc fellowship: Mitochondrial abnormalities in critical illness: role in organ failure and mortality, underlying mechanisms and therapeutic perspectives. (01/10/2008-30/09/2009)</p> </li> <li> <p>Ilse Vanhorebeek - FWO postdoc fellowship: Molecular and biochemical pathways to improvement of survival and reduced morbidity in critial illness: effects of intensive insulin therapy. (01/10/2005-30/09/2008)</p> </li> <li> <p>Lies Langouche - FWO postdoc fellowship: Mechanisms of action underlying the beneficial effects of strict normalization of blood glucose level with insulin on morbidity and mortality of critical illness. (01/10/2004-30/09/2008)</p> </li> <li> <p>Greet Van den Berghe - FWO clinical researcher FWO (01/10/1995-30/09/2004)</p> </li> </ul> </div> </section> </div> <div id="viewlet-below-content-body"> </div> <footer> <div id="viewlet-below-content"> </div> </footer> </article> </div> </div> </div>  <div id="nieuws" class="col-xs-12 col-md-4 col-block"></div>        </div> </div>   <footer class="local-footer"> <div class="footer-info"> <div class="container"> <p class="lastmodified" style="margin-bottom: 0"> Last update: Mar 01, 2023 </p> <div class="reactionfull"> <p> <span>Comments on the content and accessibility:</span> <a class="reaction" href="https://www.kuleuven.be/wieiswie/nl/person/00005103">Greet Van den Berghe</a> </p> </div> <nav class="nav-user"> <ul> <li class="lilo"> <span id="user-name"></span> <a title="Log in" href="https://gbiomed.kuleuven.be/webcms/Shibboleth.sso/Login?target=https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history" id="personaltools-login" icon="">Log in</a> </li> </ul> </nav> </div> </div> <div class="footer-navbar"> <div class="container"> <div class="flogo"></div> <div id="subnav" class="row"> </div> </div>  </div>  </footer>  </div>  <a href="#top" class="scroll-to-top"><i class="material-icons">keyboard_arrow_up</i></a>  <footer class="global-footer noindex hidden-print"> <div class="bottom-footer-kuleuven"> <div class="container"> <div class="legal"> <a href="https://www.kuleuven.be/kuleuven" class="logo" title="KU Leuven"><img class="logo-img" alt="logo" src="https://stijl.kuleuven.be/releases/latest/img/svg/logo.svg" width="107" height="38" /></a> <ul> <li> <a href="https://www.kuleuven.be/kuleuven/disclaimer.html">Disclaimer</a> </li> <li> <a href="https://admin.kuleuven.be/icts/english/cookiepolicy/">Cookie Settings</a> </li> <li> <a href="https://admin.kuleuven.be/privacy/en/">Privacy Policy</a> </li> </ul> </div> <div class="share"> <span>Follow KU Leuven on</span> <a href="https://www.facebook.com/KULeuven/"> <svg role="img" width="30" height="30" viewbox="0 0 1792 1792"> <title>facebook</title> <path d="M1376 128q119 0 203.5 84.5T1664 416v960q0 119-84.5 203.5T1376 1664h-188v-595h199l30-232h-229V689q0-56 23.5-84t91.5-28l122-1V369q-63-9-178-9-136 0-217.5 80T948 666v171H748v232h200v595H416q-119 0-203.5-84.5T128 1376V416q0-119 84.5-203.5T416 128h960z"></path> </svg> </a> <a href="https://twitter.com/KU_Leuven/"> <svg role="img" width="30" height="30" viewbox="0 0 1792 1792"> <title>twitter</title> <path d="M1408 610q-56 25-121 34 68-40 93-117-65 38-134 51-61-66-153-66-87 0-148.5 61.5T883 722q0 29 5 48-129-7-242-65T454 550q-29 50-29 106 0 114 91 175-47-1-100-26v2q0 75 50 133.5t123 72.5q-29 8-51 8-13 0-39-4 21 63 74.5 104t121.5 42q-116 90-261 90-26 0-50-3 148 94 322 94 112 0 210-35.5t168-95 120.5-137 75-162T1304 746q0-18-1-27 63-45 105-109zm256-194v960q0 119-84.5 203.5T1376 1664H416q-119 0-203.5-84.5T128 1376V416q0-119 84.5-203.5T416 128h960q119 0 203.5 84.5T1664 416z"></path> </svg> </a> <a href="https://instagram.com/kuleuven/"> <svg role="img" width="30" height="30" viewbox="0 0 1792 1792"> <title>instagram</title> <path d="M1490 1426V778h-135q20 63 20 131 0 126-64 232.5T1137 1310t-240 62q-197 0-337-135.5T420 909q0-68 20-131H299v648q0 26 17.5 43.5T360 1487h1069q25 0 43-17.5t18-43.5zm-284-533q0-124-90.5-211.5T897 594q-127 0-217.5 87.5T589 893t90.5 211.5T897 1192q128 0 218.5-87.5T1206 893zm284-360V368q0-28-20-48.5t-49-20.5h-174q-29 0-49 20.5t-20 48.5v165q0 29 20 49t49 20h174q29 0 49-20t20-49zm174-208v1142q0 81-58 139t-139 58H325q-81 0-139-58t-58-139V325q0-81 58-139t139-58h1142q81 0 139 58t58 139z"></path> </svg> </a> <a href="https://www.linkedin.com/school/ku_leuven/"> <svg role="img" width="30" height="30" viewbox="0 0 1792 1792"> <title>linkedin</title> <path d="M365 1414h231V720H365v694zm246-908q-1-52-36-86t-93-34-94.5 34-36.5 86q0 51 35.5 85.5T479 626h1q59 0 95-34.5t36-85.5zm585 908h231v-398q0-154-73-233t-193-79q-136 0-209 117h2V720H723q3 66 0 694h231v-388q0-38 7-56 15-35 45-59.5t74-24.5q116 0 116 157v371zm468-998v960q0 119-84.5 203.5T1376 1664H416q-119 0-203.5-84.5T128 1376V416q0-119 84.5-203.5T416 128h960q119 0 203.5 84.5T1664 416z"></path> </svg> </a> <a href="https://www.youtube.com/user/kuleuven/"> <svg role="img" width="30" height="30" viewbox="0 0 1792 1792"> <title>youtube</title> <path d="M1047 1303v-157q0-50-29-50-17 0-33 16v224q16 16 33 16 29 0 29-49zm184-122h66v-34q0-51-33-51t-33 51v34zM660 915v70h-80v423h-74V985h-78v-70h232zm201 126v367h-67v-40q-39 45-76 45-33 0-42-28-6-16-6-54v-290h66v270q0 24 1 26 1 15 15 15 20 0 42-31v-280h67zm252 111v146q0 52-7 73-12 42-53 42-35 0-68-41v36h-67V915h67v161q32-40 68-40 41 0 53 42 7 21 7 74zm251 129v9q0 29-2 43-3 22-15 40-27 40-80 40-52 0-81-38-21-27-21-86v-129q0-59 20-86 29-38 80-38t78 38q21 28 21 86v76h-133v65q0 51 34 51 24 0 30-26 0-1 .5-7t.5-16.5V1281h68zM913 457v156q0 51-32 51t-32-51V457q0-52 32-52t32 52zm533 713q0-177-19-260-10-44-43-73.5t-76-34.5q-136-15-412-15-275 0-411 15-44 5-76.5 34.5T366 910q-20 87-20 260 0 176 20 260 10 43 42.5 73t75.5 35q137 15 412 15t412-15q43-5 75.5-35t42.5-73q20-84 20-260zM691 519l90-296h-75l-51 195-53-195h-78l24 69 23 69q35 103 46 158v201h74V519zm289 81V470q0-58-21-87-29-38-78-38-51 0-78 38-21 29-21 87v130q0 58 21 87 27 38 78 38 49 0 78-38 21-27 21-87zm181 120h67V350h-67v283q-22 31-42 31-15 0-16-16-1-2-1-26V350h-67v293q0 37 6 55 11 27 43 27 36 0 77-45v40zm503-304v960q0 119-84.5 203.5T1376 1664H416q-119 0-203.5-84.5T128 1376V416q0-119 84.5-203.5T416 128h960q119 0 203.5 84.5T1664 416z"></path> </svg> </a> </div> </div> </div> </footer>  </div><aside class="flyout flyout-default l-flyout noindex hidden-print collapse hidden-lg-up" id="flyout-local-menu"> <nav class="nav nav-logo"> <a href="#" class="btn-toggle hidden-lg-up js-flyout-toggle flyout-toggle" role="button" aria-expanded="true" aria-controls="flyout-menu" data-toggle="collapse" data-target="#flyout-local-menu"> <span class="arrow"></span></a> </nav> <nav class="nav nav-main"> <a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine"> Laboratory of Intensive Care Medicine </a> <ul id="portal-globalnav"> <ul> <li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/research">Research</a></li> <li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/group-members">Group members</a></li> <li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/phd-projects">Students</a></li> <li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/study-protocols">Study Protocols</a></li> <li><a href="https://gbiomed.kuleuven.be/english/research/50000618/laboratory-of-intensive-care-medicine/funding-history">Funding history</a></li> <li><a href="https://www.uzleuven.be/nl/intensieve-geneeskunde">Intensive Care Unit Hospital</a></li> </ul> </ul> </nav> <nav class="nav"> <ul class="nav-language" id="flyout-lang"></ul> </nav> <hr /> <a href="https://www.kuleuven.be/kuleuven">Naar homepage kuleuven.be</a> </aside><script src="/++theme++ku-leuven-theme/js/wmsjs.js"></script><script src="https://stijl.kuleuven.be/releases/ttt/js/jquery.colorbox.js"></script></body> </html>